Publication Name	World Journal of Gastroenterology
Manuscript ID	7446
Country	Greece

Received	2013-11-20 12:27
Peer-Review Started	2013-11-20 20:41
To Make the First Decision	2013-12-16 17:29
Return for Revision	2013-12-17 19:50
Revised	2013-12-23 19:12
Second Decision	2014-01-20 19:01
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-01-20 19:31
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-02-14 20:09
Typeset the Manuscript	2014-03-23 14:30
Publish the Manuscript Online	2014-04-04 15:11

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Genetics & Heredity
Manuscript Type	Autobiography
Article Title	Association of rs1568885, rs1813443 and rs4411591 polymorphisms with anti-TNF medication response in Greek patients with Crohn’s disease
Manuscript Source	Invited Manuscript
All Author List	Diamantis Thomas, Maria Gazouli, Theodoros Karantanos, Stella Rigoglou, Georgios Karamanolis, Konstantinos Bramis, George Zografos and George E Theodoropoulos
Funding Agency and Grant Number
Corresponding Author	Maria Gazouli, Assistant Professor, Department of Basic Medical Science, Laboratory of Biology, School of Medicine, University of Athens, Michalakopoulou 176, 11527 Athens, Greece. mgazouli@med.uoa.gr
Key Words	Crohn’s disease; Treatment response; Infliximab; Polymorphisms
Core Tip	A common treatment for inflammatory bowel disease is the use of tumor necrosis factor (TNF)-a inhibitors such as Infliximab (IFX). The discovery of novel markers of response to anti-TNF agents will provide valuable information for better stratification of these patients which will eventually further improve their clinical course and quality of life. Our results suggest that the rs1568885 and rs1813443 polymorphisms are associated with clinical and biochemical response to IFX in patients with Crohn’s disease.
Publish Date	2014-04-04 15:11
Citation	Thomas D, Gazouli M, Karantanos T, Rigoglou S, Karamanolis G, Bramis K, Zografos G, Theodoropoulos GE. Association of rs1568885, rs1813443 and rs4411591 polymorphisms with anti-TNF medication response in Greek patients with Crohn’s disease. World J Gastroenterol 2014; 20(13): 3609-3614
URL	http://www.wjgnet.com/1007-9327/full/v20/i13/3609.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i13.3609

Full Article (PDF)	WJG-20-3609.pdf
Full Article (Word)	WJG-20-3609.doc
Manuscript File	7446-Review.docx
Answering Reviewers	7446-Answering reviewers.pdf
Copyright License Agreement	7446-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	7446-Language certificate.pdf
Peer-review Report	7446-Peer reviews.pdf
Scientific Editor Work List	7446-Scientific editor work list.doc